A molecular model for the triplicated a domains of human factor VIII based on the crystal structure of human ceruloplasmin

Blood

Volumn 89, Issue 7, 1997, Pages 2413-2421

  Pemberton, S ^a   Lindley, P ^b   Zaitsev, V ^b   Card, G ^b   Tuddenham, E G D ^b   Kemball Cook, G ^b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9A; CERULOPLASMIN; DISULFIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DATA BASE; GENE MAPPING; GENE MUTATION; HEMOPHILIA A; HUMAN; MISSENSE MUTATION; MOLECULAR MODEL; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0030903424     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2413     Document Type: Article

References (30)

1. Tuddenham EGD, Cooper DN: Factor VIII and haemophilia A, in The Molecular Genetics of Haemostasis and its Inherited Disorders, Oxford, UK, Oxford University, 1994 p 19
2. Kemball-Cook, G, Tuddenham EGD: The factor VIII mutation database on the World Wide Web: The haemophilia A mutation search test and resource site. HAMSTeRS update (Version 3.0). Nucleic Acids Res 25:128, 1997 (URL: http://europium.mrc.rpms. ac.uk)
3. Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Capon DJ: Structure of human factor VIII. Nature 312:337, 1984
4. McMullen BA, Fujikawa K, Davie EW, Hedner U, Ezban M: Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor FVIII (antihemophilic factor A). Protein Sci 4:740, 1995
5. Kaufman RJ, Worsley LC, Dorner AJ: Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 263:6352, 1988
6. Eaton D, Rodriguez H, Vehar GA: Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa and activated protein C with activation and inactivation of FVIII coagulant activity. Biochemistry 25:505, 1986
7. O'Brien DP, Johnson DJD, Byfield PGH, Tuddenham EGD: Inactivation of factor VIII by factor IXa. Biochemistry 31:2805, 1992
8. Fay PJ, Smudzin TM, Walker FJ: Activated protein C-catalysed inactivation of human factor VIII and factor VIIIa. J Biol Chem 266:20139, 1991
9. Fay PJ, Beattie T, Huggins CF, Regan LM: Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem 269:20522, 1994
10. 1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. J Biol Chem 271:1935, 1996
11. 2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. J Biol Chem 271:25332, 1996
12. O'Brien LM, Medved LV, Fay PJ: Location of factor IXa and factor VIIIa interactive sites. J Biol Chem 270:27087, 1995
13. Walker FJ, Scandella D, Fay PJ: Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem 265:1484, 1990
14. Foster PA, Fulcher CA, Houghten RA, Zimmerman TS: Synthetic factor FVIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor FVIII binding to phosphatidylserine. Blood 75:1999, 1990
15. Precup JW, Kline BC, Fass DN: A monoclonal antibody to factor VIII inhibits von Willebrand factor binding. Blood 77:1929, 1991
16. Marquette KA, Pittman DD, Kaufman RJ: A 110-amino acid region within the Al domain of coagulation factor VIII inhibits secretion from mammalian cells. J Biol Chem 270:10297, 1995
17. Kane WH, Davie EW: Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombolytic disorders. Blood 71:539, 1988
18. Takahashi N, Ortel TL, Putnam FW: Single chain structure of human ceruloplasmin. The complete amino acid sequence of the whole molecule. Proc Natl Acad Sci USA 81:390, 1984
19. Zaitseva I, Zaitsev V, Card G, Moshkov K, Bax B, Ralph A. Lindley P: The X-ray structure of human serum caeruloplasmin at 3.1Å: Nature of the copper centre. J Biol Inorg Chem 1:15, 1996
20. Wood WI, Capon DJ, Simonsen CC, Eaton DI, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KI, Delwart E, Tuddenham EGD, Vehar GA, Lawn RM: Expression of active human factor VIII from recombinant DNA clones. Nature 312:330, 1984
21. Elder B, Lakich D, Gitschier J: Sequence of the murine factor VIII cDNA. Genomics 16:374, 1993
22. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846, 1987
23. Guinto ER, Esmon CT, Mann KG, MacGillivray RT: The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 267:2971, 1992
24. Fleming RE, Gitlin JD: Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem 265:7701, 1990
25. Program Manual for the Wisconsin Package, Version 8, Madison, WI, Genetics Computer Group, August 1994
26. Pan Y, DeFay T, Gitschier J, Cohen F: Proposed structure of the A domains of FVIII by homology modelling. Nature Struct Biol 2:740, 1995
27. Adman ET: Copper protein structures. Adv Protein Chem 32:145, 1991
28. Messerschmidt A, Lodenstern R, Huber R, Bolognesi M, Arigliano L, Petruzzelli R, Rossi A, Finazzi-Agro A: Refined crystal structure of ascorbate oxidase at 1.9Å resolution. J Mol Biol 224:179, 1992
29. Bihoreau N, Pin S, de Kersabiec A-M, Vidot F, Fontaine-Aupart M-P: Copper atom identification in the active and inactive forms of plasma-derived FVIII and recombinant FVIII-ΔII. Eur J Biochem 222: 41, 1994
30. Pittman DD, Wang JH, Kaufman RJ: Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII. Biochemistry 31:3315, 1992